Meeting
2020 Genitourinary Cancers Symposium
A prospective comparison of MRI-planned versus CT-planned radiotherapy for prostate cancer.
Authors
Daniel R Schmidt
Beth Israel Deaconess Medical Center, Boston, MA
Daniel R Schmidt , Mandar Bhagwat , Daniel I. Glazer , Ming-Hui Chen , Anthony Victor D'Amico
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Quality of Care/Quality Improvement
Clinical Trial Registration Number
NCT02470910
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 312)
Abstract #
312
Poster Bd #
L18
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Clinical and patient-reported outcomes of fully adaptive MR-guided stereotactic radiotherapy to prostate: Real-world experience from the UK.
First Author: Prantik Das
Poster
2022 ASCO Genitourinary Cancers Symposium
Magnetic resonance imaging-guided versus computed tomography-guided stereotactic body radiotherapy for prostate cancer (MIRAGE): Interim analysis of a phase III randomized trial.
First Author: Amar Upadhyaya Kishan
Poster
2017 Genitourinary Cancers Symposium
The impact of pretreatment MRI on genitourinary and gastrointestinal toxicity after radiation therapy in patients with localized prostate cancer.
First Author: Kyle Kilinski
Poster
2017 Genitourinary Cancers Symposium
Multimodal image and mapping guided focal salvage high-dose-rate brachytherapy for local recurrent prostate cancer.
First Author: Stephane Gilles Guerif